Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method for treating eye diseases with a fusion protein of a tissue-penetrating peptide and anti-vascular endothelial growth factor

Method for treating eye diseases with a fusion protein of a tissue-penetrating peptide and anti-vascular endothelial growth factor

US Patent 11052130 · Granted Jul 6, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Heterodimeric Fc-fused cytokine and pharmaceutical composition comprising the sa2025
CH3 domain variant pair inducing formation of heterodimer of heavy chain constan2025
Method and apparatus for visual coding2025
Human antibody having high affinity to human IL-4 receptor alpha2025
OLED-based display having pixel compensation and method2025
OLED-based display having pixel compensation and method2024
Isoxazole derivatives as nuclear receptor agonists and uses thereof2024
OLED-based display having pixel compensation and method2024
Pharmaceutical composition for preventing and treating eye diseases, containing 2023
Pharmaceutical composition for preventing and treating eye diseases, containing 2023
Pharmaceutical composition for preventing and treating eye diseases, containing 2023
Pharmaceutical composition for preventing and treating eye diseases, containing 2023